Advertisement
Screener

BioAmber Inc. Accretion Expense

BioAmber Inc. Accretion Expense

BioAmber Inc. reported Accretion Expense of $1.03 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-30.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AccretionExpense · last filed 2018-03-30

  • BioAmber Inc. accretion expense for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
  • BioAmber Inc. accretion expense for the quarter ending 2016-09-30 was $774.70K, a 350.74% increase year-over-year.
  • BioAmber Inc. accretion expense for the quarter ending 2016-06-30 was $129.12K, a 24.88% decline year-over-year.
  • BioAmber Inc. accretion expense for the quarter ending 2016-03-31 was $129.12K, a 24.88% decline year-over-year.
  • BioAmber Inc. accretion expense for fiscal 2016 was $1.03M, a 0.33% increase from fiscal 2015.
  • BioAmber Inc. accretion expense for fiscal 2015 was $1.03M, a 56.78% decline from fiscal 2014.
  • BioAmber Inc. accretion expense for fiscal 2014 was $2.38M, a 383.51% increase from fiscal 2013.
  • BioAmber Inc. accretion expense for fiscal 2013 was $492.71K.
Period endAccretion Expense 3 monthAccretion Expense 6 monthAccretion Expense 9 monthAccretion Expense 12 month
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
$774.70K
derived: sum of 2 quarters · filed 2018-03-30
$903.82K
derived: sum of 3 quarters · filed 2018-03-30
$1.03M
10-K · filed 2018-03-30
2016-09-30$774.70K
10-Q · filed 2017-11-08
$903.82K
derived: sum of 2 quarters · filed 2017-11-08
$1.03M
10-Q · filed 2017-11-08
$1.55M
derived: sum of 4 quarters · filed 2018-03-30
2016-06-30$129.12K
10-Q · filed 2017-08-04
$258.23K
10-Q · filed 2017-08-04
$772.17K
derived: sum of 3 quarters · filed 2018-03-30
$944.05K
derived: sum of 4 quarters · filed 2018-03-30
2016-03-31$129.12K
10-Q · filed 2017-05-10
$643.05K
derived: sum of 2 quarters · filed 2018-03-30
$814.93K
derived: sum of 3 quarters · filed 2018-03-30
$986.80K
derived: sum of 4 quarters · filed 2018-03-30
2015-12-31$513.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
$685.81K
derived: sum of 2 quarters · filed 2018-03-30
$857.69K
derived: sum of 3 quarters · filed 2018-03-30
$1.03M
10-K · filed 2018-03-30
2015-09-30$171.88K
10-Q · filed 2016-11-07
$343.75K
derived: sum of 2 quarters · filed 2016-11-07
$515.63K
10-Q · filed 2016-11-07
$2.18M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$171.88K
10-Q · filed 2016-08-09
$343.75K
10-Q · filed 2016-08-09
$2.01M
derived: sum of 3 quarters · filed 2017-03-16
$2.25M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$171.88K
10-Q · filed 2016-05-09
$1.84M
derived: sum of 2 quarters · filed 2017-03-16
$2.08M
derived: sum of 3 quarters · filed 2017-03-16
$2.32M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$1.91M
derived: sum of 2 quarters · filed 2017-03-16
$2.15M
derived: sum of 3 quarters · filed 2017-03-16
$2.38M
10-K · filed 2017-03-16
2014-09-30$241.11K
10-Q · filed 2015-11-09
$479.60K
derived: sum of 2 quarters · filed 2015-11-09
$715.47K
10-Q · filed 2015-11-09
2014-06-30$238.49K
10-Q · filed 2015-08-05
$474.36K
10-Q · filed 2015-08-05
2014-03-31$235.87K
10-Q · filed 2015-05-11
2013-12-31$492.71K
10-K · filed 2016-03-15